| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19a2cdaf61cbcdaf77985a635b7f47b7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
1994-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8808959352bf1dfff59110c524ab75ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841613e19ad37c2985f3d5b75e2c6ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bf8ef38ba53c64ac5b11e0b848e911d |
| publicationDate |
1995-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9505161-A1 |
| titleOfInvention |
Hydrogel-based microsphere drug delivery systems |
| abstract |
The present invention provides a sustained-release delivery composition for ophthalmic drugs comprising hydrogel microspheres having a binding affinity for the drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0844001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6600011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0844001-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6132751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03031501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706787-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706787-A2 |
| priorityDate |
1993-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |